Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared on X:
“Incredibly honored to be invited by Tony Mok and the Chinese University of Hong Kong (CUHK) to deliver a lecture on DLL3-targeted treatments in SCLC.
And incredibly grateful for this amazing family of Asian friends and their marvellous hospitality!”
You can also read: DeLLphi-305: Tarlatamab–Durvalumab Redefines First-Line Maintenance in Extensive-Stage SCLC.
